PAIN TRIGGERS
Medication shortages force sudden transitions to alternative drug formulations.
Adderall IR has an intense, fast onset that can cause drowsiness or hit too hard compared to XR.
SaaS· ADHD patientsPain 7.00/10WTP 6.0/10Market 8.0/10Validation 8.0Confidence 90%Jul 17, 2026
DoseMatch: Patient-Led Medication Switch Advisor
ADHD patients forced by pharmacy shortages to switch from XR to IR Adderall lack guidance on the intense, rapid physical onset and subjective experiential differences of immediate-release medication.
adhdhealthcaremobile-apppatient-supportproductivitysaassymptom-trackerwellness
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD patients who are forced to switch from extended-release (XR) to immediate-release (IR) Adderall due to pharmacy stock shortages struggle to understand the subjective, real-world physical and experiential differences between the two formulations.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Adderall XR to IR
ADHD112
My IRs are 20mg so they can sometimes hit a little hard.
commentIt shouldn't. Obviously these things can vary from person to person, so take this with a grain of salt. I take 20mg XR to start my day and 20mg IR later as a booster. My IRs are 20mg so they can sometimes hit a little hard. They are perforated so sometimes I'll split them and only take half or take one and then take the other half later. Depends on how I'm feeling.
IR kicks in a little faster, which causes me to yawn more and want a nap more often as it is kicking in.
commentIR kicks in a little faster, which causes me to yawn more and want a nap more often as it is kicking in. And it lasts about 4-5 hours in me. Other than that, there's not really a difference. My script is 60mg XR followed by a 30IR booster, but other days I take 30mg IR 3x.
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patientsA D H D Patients Navigating Shortages
Patients suddenly transitioning from extended-release to immediate-release stimulants who need to manage onset, side effects, and split-dosing safely.
Context
Understand how switching from Adderall XR to Adderall IR will affect how they feel, specifically regarding onset, intensity, and physical sensations.
Splitting immediate-release (IR) pills to self-regulate the dosage and prevent the medication from hitting too hard all at once.
Seeking crowdsourced peer reviews and anecdotal feedback on online forums to mentally prepare for a medication change.
Current Workarounds
Searching Reddit/online forums for anecdotal dosing schedules
Manually splitting IR pills with kitchen knives to mimic XR release
Relying on trial-and-error which leads to severe crashes or anxiety
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard pharmacy and medical instructions do not prepare patients for the subjective physical sensations of IR onset versus XR release profiles.
Supply chain reliability fails, forcing patients to manage sudden dosage and formulation adjustments.
OPPORTUNITY & VALUE
Why Now
Repeated complaints about supply chain reliability forcing sudden transitions, and the intense physical/drowsy sensations of immediate release vs. extended release profiles.
Value Proposition
Unlike standard pharmacy leaflets that give generic dry warnings, this provides subjective, experiential preparation (e.g., managing the 'yawns' or rapid onset) combined with actionable pill-splitting and timing tools.
Product Direction
A personalized, evidence-and-peer-backed dosing planner and symptom tracker that helps patients map out split-dosing strategies, prepare for rapid onsets, and log physical sensations to find their optimal daily routine.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$8/moBilled monthly, cancel anytime
Model
SaaS subscription
WILLINGNESS TO PAY
Patients experiencing daily productivity loss and physical anxiety due to bad transitions will easily pay a small fee to regain physical stability and mental peace of mind during a multi-month shortage.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Navigate your medication switch without the anxiety or the crash.”
A personalized, evidence-and-peer-backed dosing planner and symptom tracker that helps patients map out split-dosing strategies, prepare for rapid onsets, and log physical sensations to find their optimal daily routine.
Core Features
Interactive split-dose simulator to visualize IR release versus XR curves
On-demand symptom & crash logger with rapid-onset anxiety relief guided breathing
Crowdsourced, pharmacist-vetted transition guides based on real patient experiences
Weekly Roadmap
1
W1-W2
Core comparison visualizer and split-dose scheduling calculator built.
- •Design visual chart comparing simulated XR release vs. IR split dosage absorption profiles
- •Build a simple calculator where users input their old XR dose and get a standard split IR layout
- •Implement strict, lawyer-approved medical disclaimers
2
W3-W4
Interactive symptom logging and custom onset alarm reminders live.
- •Build quick-tap logger for common side effects (crash, yawn, anxiety, heart-rate)
- •Implement smart notifications alerting users when their next split is due based on custom onset curves
- •Add an interactive 'Hits too hard' emergency breathing tool for rapid-onset anxiety
3
W5
Beta testing with ADHD community members and Stripe integration.
- •Integrate simple Stripe payment gate for a $19 one-time transition pass
- •Recruit 20 ADHD users from Reddit/communities to test the tracking loop
- •Refine UI based on feedback about ADHD cognitive load
4
W6
Public launch with localized shortage alerts and content marketing.
- •Publish transition calculator free tool to drive organic search/social traffic
- •Launch on Product Hunt and subreddits focusing on the US ADHD medication shortage
- •Measure premium conversion and engagement rates over the first 14 days
Launch Strategy
Partner with ADHD creators on TikTok/X, and participate in online ADHD communities (r/ADHD, r/Adderall) offering free transition calculators to drive organic traffic.
RISKS & ASSUMPTIONS
Top Risks
Medical/FDA Compliance
Providing automated split-dosing calculators can be perceived as practicing medicine without a license if not strictly designed as educational/informational tracking.
Low LTV due to Shortage Resolution
If shortages end or patients adapt within 1-2 months, churn will be high, requiring continuous cheap acquisition channels.
Inaccurate self-reporting
Patients may misattribute physical sensations to medication rather than other external lifestyle factors, rendering the data noisy.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "healthcare", "mobile-app", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "DoseMatch: Patient-Led Medication Switch Advisor" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.